Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $26.77M in the quarter ending June 30, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to $102.19M, down -8.42% year-over-year. In the year 2024, Gyre Therapeutics had annual revenue of $105.76M, down -6.78%.

• Revenue (ttm): $102.19M
• Revenue Growth: -8.42%
• P/S Ratio: 6.39
• Revenue / Employee: $176,492
• Employees: 579
• Market Cap: 683.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	105.76M	-7.69M	-6.78%
Dec 31, 2023	113.45M	11.16M	10.91%
Dec 31, 2022	102.29M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.